| Name: | TAKEDA PHARMACEUTICALS AMERICA, INC. |
| Jurisdiction: | New York |
| Legal type: | FOREIGN BUSINESS CORPORATION |
| Status: | Active |
| Date of registration: | 01 Dec 2000 (24 years ago) |
| Entity Number: | 2579493 |
| ZIP code: | 10005 |
| County: | New York |
| Place of Formation: | Delaware |
| Address: | 28 LIBERTY ST., NEW YORK, NY, United States, 10005 |
| Principal Address: | 500 Kendall Street, Cambridge, MA, United States, 02142 |
| Name | Role | Address |
|---|---|---|
| C T CORPORATION SYSTEM | DOS Process Agent | 28 LIBERTY ST., NEW YORK, NY, United States, 10005 |
| Name | Role | Address |
|---|---|---|
| C T CORPORATION SYSTEM | Agent | 28 LIBERTY ST., NEW YORK, NY, 10005 |
| Name | Role | Address |
|---|---|---|
| JULIE KIM | Chief Executive Officer | 500 KENDALL STREET, CAMBRIDGE, MA, United States, 02142 |
| Start date | End date | Type | Value |
|---|---|---|---|
| 2024-12-01 | 2024-12-01 | Address | 95 HAYDEN AVENUE, LEXINGTON, MA, 02421, USA (Type of address: Chief Executive Officer) |
| 2024-12-01 | 2024-12-01 | Address | 500 KENDALL STREET, CAMBRIDGE, MA, 02142, USA (Type of address: Chief Executive Officer) |
| 2024-10-08 | 2024-12-01 | Address | 95 HAYDEN AVENUE, LEXINGTON, MA, 02421, USA (Type of address: Chief Executive Officer) |
| 2024-10-08 | 2024-10-08 | Address | 500 KENDALL STREET, CAMBRIDGE, MA, 02142, USA (Type of address: Chief Executive Officer) |
| 2024-10-08 | 2024-10-08 | Address | 95 HAYDEN AVENUE, LEXINGTON, MA, 02421, USA (Type of address: Chief Executive Officer) |
| Filing Number | Date Filed | Type | Effective Date |
|---|---|---|---|
| 241201034336 | 2024-12-01 | BIENNIAL STATEMENT | 2024-12-01 |
| 241008004931 | 2024-10-08 | BIENNIAL STATEMENT | 2024-10-08 |
| 210115060019 | 2021-01-15 | BIENNIAL STATEMENT | 2020-12-01 |
| SR-32363 | 2019-01-28 | CERTIFICATE OF CHANGE (BY AGENT) | 2019-01-28 |
| SR-32362 | 2019-01-28 | CERTIFICATE OF CHANGE (BY AGENT) | 2019-01-28 |
Date of last update: 30 Mar 2025
Sources: New York Secretary of State
